Page last updated: 2024-10-24

muscle cell differentiation

Definition

Target type: biologicalprocess

The process in which a relatively unspecialized cell acquires specialized features of a muscle cell. [CL:0000187, GOC:go_curators]

Muscle cell differentiation is a complex process that involves a series of precisely regulated events, ultimately transforming undifferentiated precursor cells, known as satellite cells, into specialized, contractile muscle fibers. This process is essential for the development and maintenance of skeletal muscle, enabling the body's movement and force generation. Here's a detailed description of the key steps involved:

1. **Commitment and Activation:** Satellite cells reside in a quiescent state adjacent to mature muscle fibers. Upon muscle injury or growth stimuli, these cells receive signals that trigger their activation and commitment to the differentiation pathway. These signals include growth factors like fibroblast growth factor (FGF) and insulin-like growth factor (IGF), as well as cytokines and mechanical stress.

2. **Proliferation and Expansion:** Once activated, satellite cells enter the cell cycle and undergo multiple rounds of division, expanding the pool of committed progenitors. This proliferation is regulated by various signaling pathways, including the MAPK and PI3K/Akt pathways, which are activated by growth factors.

3. **Withdrawal from the Cell Cycle and Induction of Differentiation:** As the pool of committed progenitors expands, a subset of these cells receives signals that initiate the differentiation program. These signals often involve the downregulation of growth factors and the upregulation of differentiation-inducing factors, such as myostatin and Wnt proteins.

4. **Myoblast Fusion and Myotube Formation:** Committed cells, now known as myoblasts, begin expressing muscle-specific proteins, including myosin, actin, and myogenin. These proteins are essential for the formation of sarcomeres, the basic contractile units of muscle fibers. Myoblasts then undergo fusion, merging together to form multinucleated myotubes. This fusion is facilitated by specialized cell adhesion molecules, such as cadherins and integrins.

5. **Maturation and Functional Specialization:** The myotubes continue to grow and mature, acquiring their characteristic morphology and function. They establish a complex network of sarcomeres, develop a specialized internal structure, and begin to express proteins that allow for the efficient transmission of nerve impulses and calcium signaling, crucial for muscle contraction.

6. **Formation of Mature Muscle Fibers:** As the myotubes mature, they undergo a final differentiation step, becoming mature muscle fibers. These fibers are highly specialized cells, capable of generating force and contributing to the functional integrity of the muscle tissue. The process of muscle cell differentiation is tightly regulated, ensuring the proper development and maintenance of skeletal muscle throughout life. This process is essential for movement, posture, and various other physiological functions.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Nuclear receptor ROR-alphaA nuclear receptor ROR-alpha that is encoded in the genome of human. [PRO:DNx, UniProtKB:P35398]Homo sapiens (human)

Compounds (5)

CompoundDefinitionClassesRoles
tretinoinall-trans-retinoic acid : A retinoic acid in which all four exocyclic double bonds have E- (trans-) geometry.

retinoic acid : A retinoid consisting of 3,7-dimethylnona-2,4,6,8-tetraenoic acid substituted at position 9 by a 2,6,6-trimethylcyclohex-1-en-1-yl group (geometry of the four exocyclic double bonds is not specified).

Tretinoin: An important regulator of GENE EXPRESSION during growth and development, and in NEOPLASMS. Tretinoin, also known as retinoic acid and derived from maternal VITAMIN A, is essential for normal GROWTH; and EMBRYONIC DEVELOPMENT. An excess of tretinoin can be teratogenic. It is used in the treatment of PSORIASIS; ACNE VULGARIS; and several other SKIN DISEASES. It has also been approved for use in promyelocytic leukemia (LEUKEMIA, PROMYELOCYTIC, ACUTE).
retinoic acid;
vitamin A
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
t0901317T0901317: an LXRalpha and LXRbeta agonist
2-[[2-[2-(2,3-dihydro-1,4-benzodioxin-6-ylamino)-2-oxoethyl]-1-oxo-5-isoquinolinyl]oxy]propanoic acid ethyl esterisoquinolines
2-(5-butoxy-1-oxo-2-isoquinolinyl)-N-(2,3-dihydro-1,4-benzodioxin-6-yl)acetamideisoquinolines
sr1001SR1001: a selective RORalpha and RORgamma inverse agonist; structure in first sourcesulfonamide